CCBE1 promotes GIST development through enhancing angiogenesis and mediating resistance to imatinib

Gastrointestinal stromal tumor (GIST) is the most major mesenchymal neoplasm of the digestive tract. Up to now, imatinib mesylate has been used as a standard first-line treatment for irresectable and metastasized GIST patients or adjuvant treatment for advanced GIST patients who received surgical re...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Guang-Ang, Zhu, Chun-Chao, Zhang, Xiao-Xin, Zhu, Lei, Yang, Xiao-Mei, Jiang, Shu-Heng, Li, Rong-Kun, Tu, Lin, Wang, Yang, Zhuang, Chun, He, Ping, Li, Qing, Cao, Xiao-Yan, Cao, Hui, Zhang, Zhi-Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978997/
https://www.ncbi.nlm.nih.gov/pubmed/27506146
http://dx.doi.org/10.1038/srep31071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978997/
https://www.ncbi.nlm.nih.gov/pubmed/27506146
http://dx.doi.org/10.1038/srep31071

Ejemplares similares